Nath Bio-Genes (I)

Quarterly
Consolidated
ParticularsJun '25Sep '25Dec '25Mar '26Jun '26
Revenue285.4645.7867.7053.97330.30
Expenses258.5942.3967.9052.73298.52
EBITDA31.058.045.316.8637.06
Operating Profit32.149.127.027.0837.24
Profit Before Tax28.945.462.472.4932.98
Net Profit28.284.821.60-0.0132.26
Financial Ratios
Operating Profit Margin11.67%23.03%12.13%15.72%11.65%
Net Profit Margin9.26%6.84%-0.32%-0.02%9.47%
Earning Per Share (Diluted)14.882.530.89-0.7916.98
Dividends Per Share0.000.000.000.000.00